MiNK Therapeutics’ iNKT Cell Therapy Highlighted as Key in New Paediatric Cancer Initiative
Market Chameleon (Tue, 10-Mar 10:30 AM)
MiNK Therapeutics Secures $1.1 Million Collaboration With C-Further to Advance PRAME-Targeted iNKT Therapy for Pediatric Cancers
Market Chameleon (Tue, 10-Mar 7:05 AM)
